VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $290,670 | -21.7% | 10,142 | -34.1% | 0.08% | -20.0% |
| Q3 2022 | $371,000 | -61.8% | 15,399 | -56.6% | 0.10% | -62.6% |
| Q2 2022 | $971,000 | -29.2% | 35,449 | -0.9% | 0.28% | -7.6% |
| Q1 2022 | $1,372,000 | +16.0% | 35,775 | -3.1% | 0.30% | +27.2% |
| Q4 2021 | $1,183,000 | +8.7% | 36,919 | 0.0% | 0.24% | +1.3% |
| Q3 2021 | $1,088,000 | -15.1% | 36,919 | -2.1% | 0.24% | -11.9% |
| Q2 2021 | $1,282,000 | -25.1% | 37,719 | -28.4% | 0.27% | -29.7% |
| Q1 2021 | $1,712,000 | -23.3% | 52,675 | -14.9% | 0.38% | -30.0% |
| Q4 2020 | $2,231,000 | -8.5% | 61,925 | -0.6% | 0.54% | -3.4% |
| Q3 2020 | $2,439,000 | +13.8% | 62,280 | +6.6% | 0.56% | +0.7% |
| Q2 2020 | $2,143,000 | – | 58,430 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |